TRL.H · Trilogy International Partners Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q1 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $83.16M | $0 | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $3.41M | $1.45M | $31.00M | - | - | - | - | - | - | - |
| Total Operating Expenses | $3.41M | $1.46M | $149.11M | - | - | - | - | - | - | - |
| D&A | - | - | $18.12M | - | - | - | - | - | - | - |
| Operating Income | ($3.41M) | $463.49M | $6.24M | - | - | - | - | - | - | - |
| Interest Expense | $0 | $8.56M | $0 | - | - | - | - | - | - | - |
| Income Tax | $0 | $5.15M | $6.18M | - | - | - | - | - | - | - |
| Net Income | ($5.43M) | ($1.24M) | ($29.81M) | - | - | - | - | - | - | - |
| EPS - Basic | ($0.06) | ($0.01) | ($0.02) | - | - | - | - | - | - | - |
| EPS - Diluted | ($0.06) | ($0.01) | ($0.34) | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q1 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.31M | $30.27M | $21.74M | $25.07M | $53.49M | $71.21M | $76.73M | - | $43.94M | $47.09M |
| Accounts Receivable | - | - | - | $0 | $61.07M | $55.45M | $60.88M | - | $71.92M | $75.03M |
| Inventory | - | - | - | $0 | $10.92M | $14.61M | $19.48M | - | $45.96M | $21.35M |
| Accounts Payable | $10.0K | $62.0K | $31.0K | $49.0K | $27.17M | $19.91M | $28.50M | - | $36.72M | $33.55M |
| Current Assets | $9.57M | $30.67M | $36.34M | $40.63M | $200.84M | $254.94M | $214.41M | - | $198.58M | $200.72M |
| Total Assets | $10.74M | $31.91M | $37.66M | $40.64M | $803.87M | $989.03M | $838.63M | - | $728.28M | $761.04M |
| Current Liabilities | $891.0K | $1.04M | $5.50M | $7.18M | $225.62M | $219.11M | $233.53M | - | $232.27M | $220.18M |
| Long-term Debt | - | - | - | - | $10.40M | - | $528.74M | - | $498.53M | $496.55M |
| Total Liabilities | $1.11M | $1.30M | $5.82M | $7.18M | $1.05B | $1.03B | $846.42M | - | $761.90M | $754.85M |
| Stockholders' Equity | $9.63M | $30.60M | ($271.88M) | $33.46M | ($280.89M) | ($81.45M) | ($63.28M) | ($29.23M) | ($71.59M) | ($47.20M) |
| Retained Earnings | $9.63M | $30.60M | $31.84M | $33.46M | ($288.24M) | ($97.37M) | ($71.13M) | - | ($75.31M) | ($53.26M) |
Cash Flow
| Line item | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q1 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $19.67M | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | ($27.01M) | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | $7.71M | - | - | - | - | - | - | - |
| CapEx | - | - | $26.33M | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | ($6.66M) | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q1 '19 | Q4 '18 | Q4 '17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | 557.3% | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | -1.5% | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | 0.22 | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 1.7% | - | - | - | - | - | - | - | - |
| Effective tax rate | - | 131.6% | - | - | - | - | - | - | - | - |
| Return on assets | -50.5% | -3.9% | -79.2% | - | - | - | - | - | - | - |
| Return on equity | -56.3% | -4.0% | 11.0% | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 10.74 | 29.49 | 6.61 | 5.66 | 0.89 | 1.16 | 0.92 | - | 0.85 | 0.91 |
| Quick ratio | 10.74 | 29.49 | 6.61 | 5.66 | 0.84 | 1.10 | 0.83 | - | 0.66 | 0.81 |
| Cash ratio | 10.45 | 29.11 | 3.96 | 3.49 | 0.24 | 0.33 | 0.33 | - | 0.19 | 0.21 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | -0.04 | - | -8.36 | - | -6.96 | -10.52 |
| Debt / Assets | - | - | - | - | 0.01 | - | 0.63 | - | 0.68 | 0.65 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | 54.1x | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.12 | 1.04 | -0.14 | 1.21 | -2.86 | -12.14 | -13.25 | - | -10.17 | -16.12 |
| Liabilities / Assets | 0.10 | 0.04 | 0.15 | 0.18 | 1.31 | 1.04 | 1.01 | - | 1.05 | 0.99 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | 2.61 | 0.00 | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | -244.8% | -28.7% | 11.6% | - | -51.7% | 85.1% |
Peer comparison
Same SIC group: Radiotelephone Communications
Comparing Trilogy International Partners Inc. against the 5 most active filers in the same SIC group.